MassDevice remains the place to go if you want the rundown on earnings season in medtech. This episode's coverage includes a discussion of Masimo's second-quarter performance, which included a significant reduction in the company's 2023 sales guidance. Fast Five hosts Sean Whooley and Danielle Kirsh break down what contributed to the results and why Masimo remains optimistic in the face of some adversity.

Elsewhere, more medtech companies are looking to raise awareness of their offerings through clever marketing campaigns. Staar Surgical announced a collaboration with NFL quarterback Will Levis to promote the company's implantable collamer lenses (ICLs). Levis received the ocular implants to enhance his vision ahead of his first season as a professional football player with the Tennessee Titans. Learn more about what these implantable lenses do for people with myopia and beyond.

SS Innovations made the first international sale of its SSi Mantra surgical robotic platform. The robot provides capabilities for multi-specialty uses, including cardiothoracic, head and neck, gynecology, urology, general surgery and more. Find out where the company made that sale and what is on the horizon as it looks to enter more geographies.

In an interesting play to enhance its neurorehabilitation offerings, ReWalk Robotics acquired a company that develops anti-gravity technology. Find out how that company, AlterG, uses this NASA-derived technology to aid in physical and neurological rehabilitation and hear the hosts break down the details of the acquisition.

As ablation continues to be a vital approach for treating AFib, there's a new option set to hit the market. Boston Scientific announced that it received FDA approval for its POLARx cryoablation balloon catheter, designed to address the limitations of current cryoablation offerings.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.